Cover Image
市場調查報告書

低心搏量症候群:全球臨床實驗趨勢

Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 214946
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
低心搏量症候群:全球臨床實驗趨勢 Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2016
出版日期: 2016年10月31日 內容資訊: 英文 41 Pages
簡介

本報告提供全球低心搏量症候群治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 低心搏量症候群
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管系統疾病治療藥臨床實驗上低心搏量症候群的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心血管系統疾病治療藥臨床實驗上低心搏量症候群的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

低心搏量症候群治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Tenax Therapeutics, Inc.
    • PT Kalbe Farma Tbk
    • Phyxius Pharma, Inc.
    • Ludwig Boltzmann Gesellschaft
  • 有代表性的研究機關·醫院臨床實驗概要
    • Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz
    • Bambino Gesu Hospital and Research Institute
    • Birmingham Medical Center
    • Fujita Health University
    • Fundacion Publica Andaluza para la Investigacion de Malaga en Biomedicina y Salud
    • Universita Vita-Salute San Raffaele
    • Universite Catholique de Louvain
    • University of Lubeck
    • University of Sao Paulo

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3856CTIDB

GlobalData's clinical trial report, "Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Low Cardiac Output Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Low Cardiac Output Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Central and South America 12
  • Clinical Trials by G7 Countries: Proportion of Low Cardiac Output Syndrome to Cardiovascular Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Low Cardiac Output Syndrome to Cardiovascular Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Low Cardiac Output Syndrome Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Latest Clinical Trials News on Low Cardiac Output Syndrome 28
  • Oct 05, 2016: Tenax Therapeutics Provides Clinical Updates for Lead Candidate Levosimendan 28
  • Clinical Trial Profile Snapshots 29

Appendix 38

  • Abbreviations 38
  • Definitions 38
  • Research Methodology 39
  • Secondary Research 39
  • About GlobalData 40
  • Contact Us 40
  • Disclaimer 40
  • Source 41

List of Tables

  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
  • Proportion of Low Cardiac Output Syndrome to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 13
  • Low Cardiac Output Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Low Cardiac Output Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Low Cardiac Output Syndrome to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 16
  • Low Cardiac Output Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Low Cardiac Output Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 19
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Low Cardiac Output Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures

  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Proportion of Low Cardiac Output Syndrome to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 13
  • Low Cardiac Output Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Low Cardiac Output Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Low Cardiac Output Syndrome to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 16
  • Low Cardiac Output Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Low Cardiac Output Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
  • Low Cardiac Output Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Low Cardiac Output Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Low Cardiac Output Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
  • GlobalData Methodology 39
Back to Top